New immunotherapy agent is safe and shows promise against high-risk prostate cancers
A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce… Read More »New immunotherapy agent is safe and shows promise against high-risk prostate cancers